Concepedia

Oliver Plöttner

OP

6

Publications

548

Citations

6

H-Index

1998

Active since

Affiliations

Roche Pharma AG (Germany)(Current)

University of Würzburg

Max Planck Institute of Biochemistry

Oliver Plöttner is an author at Roche Pharma AG (Germany) specializing in medicine, neuroscience, and social sciences.

ORCID

Top concepts

Publications per year

1998–2017

6

Publications

6

Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders

Georg Stoll, Olli Pietiläinen, Bastian Linder et al. · Nature Neuroscience · 2013 · 172 citations · Full text

, , +10

IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)

Ulf‐Peter Guenther, Lusy Handoko, Bernhard Laggerbauer et al. · Human Molecular Genetics · 2009 · 130 citations · Full text

Cloning and characterization of Dlk, a novel serine/threonine kinase that is tightly associated with chromatin and phosphorylates core histones

Donat Kögel, Oliver Plöttner, Gerd Landsberg et al. · Oncogene · 1998 · 114 citations

, , +11

Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP

Bastian Linder, Oliver Plöttner, Enno Hartmann et al. · Human Molecular Genetics · 2008 · 86 citations · Full text

Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function

Oliver Popp, Samuel Moser, Jörg Zielonka et al. · mAbs · 2017 · 28 citations · Full text

Rows per page

1–5 of 6